Trademark: 79367170
Word
HELAXA
Status
Pending
Status Code
802
Status Date
Thursday, September 5, 2024
Serial Number
79367170
Mark Type
3
Filing Date
Saturday, December 3, 2022
Published for Opposition
Tuesday, August 6, 2024

Trademark Owner History
Helaxa GmbH & Co. KG - Owner At Publication

Classifications
5 Pharmaceuticals, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medical preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; veterinary preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; pharmaceutical preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicinal healthcare preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicinal preparations and substances, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicines for human purposes, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicines for veterinary purposes, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; nutritional supplements for human purposes; nutritional supplements for veterinary use; dietetic foods adapted for medical purposes
3 Non- medical cosmetics
1 Chemicals for use in industry and science; biological preparations for use in industry and science; all the aforementioned goods not in relation to food and food production
42 Scientific and technological services and research and design relating thereto, namely, scientific research in the medical and pharmaceutical fields and design relating thereto, namely, design and testing of new products for others; industrial analysis and research services in the medical and pharmaceutical fields; industrial design; research and development of new products for others; medical research services; technical research services in the medical and pharmaceutical fields; quality control for others; chemical analysis; medical and scientific research, namely, conducting clinical trials for others; chemical laboratories; technological research in the medical and pharmaceutical fields; scientific research
The mark consists of the stylized wording "HELAXA" with the letters "HELA" in blue, "X" with the left half in orange and the right half in pink with purple shading, and the last "A" in blue, all on a transparent background.
The color(s) blue, orange, pink, and purple is/are claimed as a feature of the mark.

Trademark Events
Apr 7, 2023
Sn Assigned For Sect 66a Appl From Ib
Apr 10, 2023
New Application Office Supplied Data Entered
Apr 14, 2023
Application Filing Receipt Mailed
Sep 2, 2023
Limitation Of Goods Received From Ib
Sep 12, 2023
Assigned To Examiner
Sep 15, 2023
Non-Final Action Written
Sep 16, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Sep 29, 2023
Refusal Processed By Mpu
Sep 29, 2023
Limitation From The Ib - Request Exam Review
Sep 29, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Oct 25, 2023
Refusal Processed By Ib
Feb 5, 2024
Teas Response To Office Action Received
Feb 5, 2024
Correspondence Received In Law Office
Feb 6, 2024
Teas/Email Correspondence Entered
Feb 26, 2024
Non-Final Action Written
Feb 26, 2024
Non-Final Action E-Mailed
Feb 26, 2024
Notification Of Non-Final Action E-Mailed
Mar 16, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 16, 2024
Teas Change Of Correspondence Received
Mar 16, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 16, 2024
Teas Change Of Owner Address Received
Mar 16, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 26, 2024
Refusal Processed By Ib
Jun 4, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 4, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 4, 2024
Teas Change Of Correspondence Received
Jun 27, 2024
Teas/Email Correspondence Entered
Jun 27, 2024
Correspondence Received In Law Office
Jun 27, 2024
Teas Response To Office Action Received
Jul 1, 2024
Approved For Pub - Principal Register
Jul 17, 2024
Notification Of Notice Of Publication E-Mailed
Aug 6, 2024
Published For Opposition
Aug 6, 2024
Official Gazette Publication Confirmation E-Mailed
Sep 4, 2024
Notification Of Possible Opposition Sent To Ib
Sep 4, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Sep 5, 2024
Extension Of Time To Oppose Received
Sep 20, 2024
Notification Of Possible Opposition - Processed By Ib

Trademark Alertz updated from USPTO on 2030-01-24